Patent · US Active

Longer-acting progestin prodrug contraceptives

US10624903B2 · kind B2 · utility

0Cited by
12References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 14, 2018
Grant dateApr 21, 2020
Priority date—
Expiry dateSep 14, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07J43/003
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are progestin compounds that have extended release rates and that can be used without an estrogen to produce a contraceptive state.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.